Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • netpumber
    Member
    • May 2014
    • 21

    #1

    RNA-seq and expression analysis with 3 iterations in each treatment - cuffmerge stage

    Hi!

    First of all i have to draw the experiment.

    There are 3 (4 with wt) treatments with 3 iterations each one which have been RNA sequenced.
    Treatm_1 (x3)
    Treatm_2 (x3)
    Treatm_3 (x3)
    WT (x3)

    The goal is to calculate the differential expression between each treatment and the wt.

    The protocol i chose to use is the one referred at stringtie's web page.

    #1
    So in the first stage i aligned all reads with the reference genome with tophat2

    Code:
    tophat2 -o Treatm1.1_tophat_output --microexon-search -G ~/Projects/RefGenes/genes.gtf ~/Projects/Sequence/Bowtie2Index/genome Treatm1.1_1.fastq Treatm1.1_2.fastq
    Did that for each treatment and iteration.

    #2

    In the second step run the assembler stringtie for each treatment and iteration again.

    Code:
    stringtie -G ~/Projects/RefGenes/genes.gtf -o Treatm1.1_stringtie_output -p 3 Treatm1.1_tophat_output/accepted_hits.bam
    Also off the record, in that step stringtie returned that single warning that i couldn't find what really means.

    Warning: bundle chr12:70257058-70462447(2179480) (27js) reached coverage saturation (1000000) starting with read mapped at 70260345
    #3

    In that step my question was born. At stringtie's site they say:

    Just like in the Cufflinks protocol, this Cuffmerge run will take as input all the assembled transcripts (GTF files) produced by StringTie for each sample, and also the reference annotation if available.
    Should i run the cuffmerge for all treatments and their iterations at once or each iteration from each treatment every time ?

    I mean should i run this command: (?)

    Code:
    cuffmerge -g ~/Projects/RefGenes/genes.gtf -p 3 -s ~/Projects/Sequence/Bowtie2Index/genome assembled_list.txt
    where assembled_list.txt will have

    Treatm1.1_stringtie_output
    Treatm1.2_stringtie_output
    Treatm1.3_stringtie_output
    Treatm2.1_stringtie_output
    Treatm2.2_stringtie_output
    Treatm2.3_stringtie_output
    Treatm3.1_stringtie_output
    Treatm3.2_stringtie_output
    Treatm3.3_stringtie_output
    wt.1_stringtie_output
    wt.2_stringtie_output
    wt.3_stringtie_output
    or this one: (?)

    Code:
    cuffmerge -g ~/Projects/RefGenes/genes.gtf -p 3 -s ~/Projects/Sequence/Bowtie2Index/genome assembled_list.txt
    where assembled_list.txt will have

    Treatm1.1_stringtie_output
    Treatm2.1_stringtie_output
    Treatm3.1_stringtie_output
    wt.1_stringtie_output
    and then run again with these in assembled_list.txt

    where assembled_list.txt will have

    Treatm1.2_stringtie_output
    Treatm2.2_stringtie_output
    Treatm3.2_stringtie_output
    wt.2_stringtie_output
    and finally run it with assembled_list.txt

    Treatm1.3_stringtie_output
    Treatm2.3_stringtie_output
    Treatm3.3_stringtie_output
    wt.3_stringtie_output
    Thank you.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...